News
Ohio giant Cardinal Health makes $1.9 billion urology deal
Dublin, Ohio-based Cardinal Health raised its fiscal 2026 adjusted earnings per share forecast to $9.30 to $9.50, ahead of analyst estimates. The company distributes pharmaceuticals, manufactures medical and laboratory products, and supplies home-health and direct-to-patient products and services.
Cardinal Announces Acquisition of Solaris Health for $1.9 Billion
Cardinal Health's Specialty Alliance will acquire Solaris Health for $1.9 billion, enhancing its urology capabilities. The acquisition aligns with Cardinal's strategic focus on specialty growth and is expected to close by the end of 2025.
The S&P 500 rose 1.1% on Tuesday, Aug. 12, 2025, reaching a record high as a tame inflation report boosted expectations for a ...
2d
Cardinal Health's $1.9 Billion Urology Bet Sends Shares Sliding -- But Could Spark Long-Term Growth
Cardinal Health is making another big move in specialty healthcare, agreeing to acquire Solaris Health for $1.9 billion. The ...
Cardinal Health will acquire Solaris Health, a urology management services organization, for around $1.9 billion in cash.
This episode of Pharma Pulse dives into Cardinal Health’s acquisition of Solaris Health to strengthen specialty services, how ...
Cardinal Health (CAH) is falling after announcing a $1.9 billion deal to acquire Solaris Health, aiming to expand in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback